2012
DOI: 10.1016/j.snb.2012.05.077
|View full text |Cite
|
Sign up to set email alerts
|

Biosensors for cardiac biomarkers detection: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
209
0
2

Year Published

2014
2014
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 342 publications
(211 citation statements)
references
References 93 publications
0
209
0
2
Order By: Relevance
“…The major impetus in the research and development of such virus sensors is their practical features such as the ease of operation, simple and straightforward device fabrication, possibility to integrate synthetic or natural antibodies, rapid response, high selectivity and cross-sensitivity, portability, and miniaturization capability. It is due to these advantages that biosensors have not only been widely employed for virus recognition [14], but have also been applied for the detection of microorganism such as pathogenic bacteria [15,16] and yeast [17][18][19][20], living blood cells [21][22][23], and different diseases biomarkers [24,25].…”
Section: Introductionmentioning
confidence: 99%
“…The major impetus in the research and development of such virus sensors is their practical features such as the ease of operation, simple and straightforward device fabrication, possibility to integrate synthetic or natural antibodies, rapid response, high selectivity and cross-sensitivity, portability, and miniaturization capability. It is due to these advantages that biosensors have not only been widely employed for virus recognition [14], but have also been applied for the detection of microorganism such as pathogenic bacteria [15,16] and yeast [17][18][19][20], living blood cells [21][22][23], and different diseases biomarkers [24,25].…”
Section: Introductionmentioning
confidence: 99%
“…cTnI is only restricted inside the myocardium and it is currently considered to be the standard biomarker test for detecting AMI, because it is significantly more specific than other cardiac biomarkers [18]. The levels of cTnI in healthy humans are normally lower than 0.1 ng mL −1 , and a level between 0.1and 2 ng mL −1 indicates a diagnosis of unstable angina and other heart disorder, whereas levels greater than 2 ng mL −1 indicate an increased risk for future serious heart events [19]. This emphasizes the need for developing diagnostic tools which are highly sensitive, cost effective, and utilizing existing large-scale manufacturing techniques.…”
Section: Introductionmentioning
confidence: 99%
“…These are the largest single cause of death in the EU, accounting 42% deaths in 2010 [1]. Following cardiovascular biomarkers is a key tool in the fight against cardiovascular diseases, aimed at preserving the patient's life and delivering effective therapies and a successful prognosis for the disease [2][3][4].…”
Section: Introductionmentioning
confidence: 99%
“…× × × × × (Bio)Sensors could be an alternative, because they allow rapid diagnosis in point-of-care, providing reduced response times and leading to better outcomes of the disease, most especially in acute events [2,14]. The receptor element is at the core of the device selectivity, an essential condition for detecting proteins that circulate in the blood at quite low concentrations.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation